🚀 VC round data is live in beta, check it out!

China Feihe Valuation Multiples

Discover revenue and EBITDA valuation multiples for China Feihe and similar public comparables like NH Foods, Cranswick, Orion (Spin Co), Uni-President China and more.

China Feihe Overview

About China Feihe

China Feihe is China's largest infant milk formula producer, with a premium market positioning among domestic and foreign competing brands. The company utilizes the flagship Astrobaby lineup to promote its “more suitable for Chinese babies” proposition. It has a nationwide distributor network covering maternity stores, supermarkets and traditional retailers, as well as a direct sales network in e-commerce.


Founded

2012

HQ

China

Employees

9.6K

Website

feihe.com

Financials (LTM)

Revenue: $3B
EBITDA: $589M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

China Feihe Financials

China Feihe reported last 12-month revenue of $3B and EBITDA of $589M.

In the same LTM period, China Feihe generated $2B in gross profit, $589M in EBITDA, and $305M in net income.

Revenue (LTM)


China Feihe P&L

In the most recent fiscal year, China Feihe reported revenue of $3B and EBITDA of $576M.

China Feihe is profitable as of last fiscal year, with gross margin of 65%, EBITDA margin of 22%, and net margin of 11%.

See analyst estimates for China Feihe
LTMLast FY202320242025202620272028
Revenue$3B$3B$3B$3B$3B
Gross Profit$2B$2B$2B$2B$2B
Gross Margin65%65%65%66%65%
EBITDA$589M$576M$807M$914M$571M
EBITDA Margin22%22%28%30%22%
EBIT Margin19%19%26%27%19%
Net Profit$305M$284M$497M$523M$284M
Net Margin11%11%17%17%11%

Financial data powered by Morningstar, Inc.

China Feihe Stock Performance

China Feihe has current market cap of $4B, and enterprise value of $2B.

Market Cap Evolution


China Feihe's stock price is $0.44.

China Feihe share price decreased by 42.8% in the last year.

China Feihe has an EPS (earnings per share) of $0.03.

See more trading valuation data for China Feihe
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$4B-0.0%0.0%-8.5%-42.8%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

China Feihe Valuation Multiples

China Feihe trades at 0.6x EV/Revenue multiple, and 2.8x EV/EBITDA.

See NTM and 2027E valuation multiples for China Feihe

EV / Revenue (LTM)


China Feihe Financial Valuation Multiples

As of May 3, 2026, China Feihe has market cap of $4B and EV of $2B.

China Feihe has a P/E ratio of 12.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.6x0.6x0.6x0.6x
EV/EBITDA2.8x2.9x2.1x1.8x2.9x
EV/EBIT3.3x3.3x2.2x2.1x3.3x
EV/Gross Profit1.0x1.0x0.9x0.8x1.0x
P/E12.8x13.8x7.9x7.5x13.8x
EV/FCF6.4x8.1x4.4x4.3x17.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified China Feihe Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

China Feihe Margins & Growth Rates

China Feihe grew revenue by 3% and EBITDA by 6% in the last fiscal year.

In the most recent fiscal year, China Feihe reported gross margin of 65%, EBITDA margin of 22%, and net margin of 11%.

See estimated margins and future growth rates for China Feihe

China Feihe Margins

Last FY202420252026202720282029
Gross Margin65%66%65%66%
EBITDA Margin22%30%22%22%
EBIT Margin19%27%19%19%
Net Margin11%17%11%13%
FCF Margin8%13%4%14%

China Feihe Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%6%(13%)3%
Gross Profit Growth5%9%(14%)5%
EBITDA Growth6%13%(38%)7%
EBIT Growth2%8%(37%)2%
Net Profit Growth26%5%(46%)26%
FCF Growth80%3%(76%)294%

Data powered by FactSet, Inc. and Morningstar, Inc.

China Feihe Operational KPIs

China Feihe's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

China Feihe's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

China Feihe's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for China Feihe
LTMLast FY202320242025202620272028
Rule of 4026%25%———
Bessemer Rule of X31%30%———
Revenue per Employee—$0.3M———
Opex per Employee—$0.1M———
S&M Expenses to Revenue40%40%34%35%40%
G&A Expenses to Revenue9%9%9%5%6%
R&D Expenses to Revenue—3%—3%3%
Opex to Revenue—46%38%40%46%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

China Feihe Competitors

China Feihe competitors include NH Foods, Cranswick, Orion (Spin Co), Uni-President China, Vita Coco, a2 Milk, Coca-Cola Andina, United Breweries, Yamazaki Baking and Kewpie.

Most China Feihe public comparables operate across Food & Beverages and Baby & Child Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
NH Foods0.5x0.5x9.1x7.5x
Cranswick1.1x1.0x10.6x9.1x
Orion (Spin Co)1.3x1.3x6.1x5.9x
Uni-President China0.7x0.7x5.8x6.3x
Vita Coco5.9x5.6x36.9x32.3x
a2 Milk2.9x2.8x17.5x19.6x
Coca-Cola Andina1.3x1.3x6.9x6.9x
United Breweries3.9x4.1x41.6x41.7x

This data is available for Pro users. Sign up to see all China Feihe competitors and their valuation data.

Start Free Trial

China Feihe M&A Activity

China Feihe has acquired 1 company to date.

Last acquisition by China Feihe was on December 19th 2017. China Feihe acquired Vitamin World for $28M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by China Feihe

Vitamin World
Description
Vitamin World is a nationwide retailer of vitamins and nutritional supplements with over 380 stores across the United States. It sources premium ingredients globally to formulate high-potency products for wellness needs ranging from immunity to fitness. Trained associates in each location provide personalized guidance to customers from beginners to enthusiasts. Headquartered in Hauppauge, New York, the brand emphasizes purity and freshness in its offerings since its founding in 1976.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date19 Dec 2017
Valuation$28M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all China Feihe acquisitions and their M&A valuation multiples.

Start Free Trial

China Feihe Investment Activity

China Feihe has invested in 1 company to date.

Latest investment by China Feihe was on March 1st 2021. China Feihe invested in Gushengtang Holdings in their $38M Series E round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by China Feihe

Gushengtang Holdings
Description
Gushengtang Holdings Ltd is a traditional chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. All of the group’s revenue is derived from the PRC.
HQ CountryChina
HQ City
Guangzhou
Deal Date1 Mar 2021
RoundSeries E
Raised$38M
InvestorsEight Roads Ventures; China Feihe; Long Hill Capital; New Enterprise Associates
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all China Feihe investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About China Feihe

When was China Feihe founded?China Feihe was founded in 2012.
Where is China Feihe headquartered?China Feihe is headquartered in China.
How many employees does China Feihe have?As of today, China Feihe has over 9K employees.
Who is the CEO of China Feihe?China Feihe's CEO is Youbin Leng.
Is China Feihe publicly listed?Yes, China Feihe is a public company listed on HKEX.
What is the stock symbol of China Feihe?China Feihe trades under 06186 ticker.
When did China Feihe go public?China Feihe went public in 2019.
Who are competitors of China Feihe?China Feihe main competitors include NH Foods, Cranswick, Orion (Spin Co), Uni-President China, Vita Coco, a2 Milk, Coca-Cola Andina, United Breweries, Yamazaki Baking, Kewpie.
What is the current market cap of China Feihe?China Feihe's current market cap is $4B.
What is the current revenue of China Feihe?China Feihe's last 12 months revenue is $3B.
What is the current revenue growth of China Feihe?China Feihe revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of China Feihe?Current revenue multiple of China Feihe is 0.6x.
Is China Feihe profitable?Yes, China Feihe is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of China Feihe?China Feihe's last 12 months EBITDA is $589M.
What is China Feihe's EBITDA margin?China Feihe's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of China Feihe?Current EBITDA multiple of China Feihe is 2.8x.
What is the current FCF of China Feihe?China Feihe's last 12 months FCF is $262M.
What is China Feihe's FCF margin?China Feihe's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of China Feihe?Current FCF multiple of China Feihe is 6.4x.
How many companies China Feihe has acquired to date?As of May 2026, China Feihe has acquired 1 company.
What was the largest acquisition by China Feihe?$28M acquisition of Vitamin World on 19th December 2017 was the largest M&A China Feihe has done to date.
What companies China Feihe acquired?China Feihe acquired Vitamin World.
In how many companies China Feihe has invested to date?As of May 2026, China Feihe has invested in 1 company.
What was the last China Feihe investment?On 1st March 2021 China Feihe invested in Gushengtang Holdings, participating in a $38M Series E round, alongside Eight Roads Ventures, Long Hill Capital, and New Enterprise Associates.
In what companies China Feihe invested in?China Feihe invested in Gushengtang Holdings.

See public comps similar to China Feihe

Lists including China Feihe

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial